Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

372 ARTÍCULOS , VIENDO DEL 151 AL 165

Calcium channel blocking as a therapeutic strategy for Alzheimer's disease: the case for isradipine

Anekonda TS, Quinn JF.

Biochim Biophys Acta. 2011 Dec;1812(12):1584-90. doi: 10.1016/j.bbadis.2011.08.013. Epub 2011 Sep 8.

Therapeutic compliance of nanomedicine in Alzheimer's disease

Wilson B.

Nanomedicine (Lond). 2011 Sep;6(7):1137-9. doi: 10.2217/nnm.11.114.

Antioxidant pathways in Alzheimer's disease: possibilities of intervention

Viña J, Lloret A, Giraldo E, Badia MC, Alonso MD.

Curr Pharm Des. 2011 Dec;17(35):3861-4. doi: 10.2174/138161211798357755.

Use of memantine for the treatment of dementia

Lo D, Grossberg GT.

Expert Rev Neurother. 2011 Oct;11(10):1359-70. doi: 10.1586/ern.11.132.

Effect of a medical food on body mass index and activities of daily living in patients with Alzheimer's disease: secondary analyses from a randomized, controlled trial

Kamphuis PJ, Verhey FR, Olde Rikkert MG, Twisk JW, Swinkels SH, Scheltens P.

J Nutr Health Aging. 2011 Aug;15(8):672-6. doi: 10.1007/s12603-011-0339-3.

A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor

Weinreb O, Amit T, Bar-Am O, Youdim MB.

Int Rev Neurobiol. 2011;100:191-215. doi: 10.1016/B978-0-12-386467-3.00010-8.

APP transgenic mice and their application to drug discovery

Howlett DR.

Histol Histopathol. 2011 Dec;26(12):1611-32. doi: 10.14670/HH-26.1611.

Clinical research on comprehensive treatment of senile vascular dementia

Chen LP, Wang FW, Zuo F, Jia JJ, Jiao WG.

J Tradit Chin Med. 2011 Sep;31(3):178-81. doi: 10.1016/s0254-6272(11)60036-8.

Current and emerging drug treatment options for Alzheimer's disease: a systematic review

Herrmann N, Chau SA, Kircanski I, Lanctôt KL.

Drugs. 2011 Oct 22;71(15):2031-65. doi: 10.2165/11595870-000000000-00000.

Alzheimer's disease, autoimmunity and inflammation. The good, the bad and the ugly

Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G.

Autoimmun Rev. 2011 Dec;11(2):149-53. doi: 10.1016/j.autrev.2011.09.005. Epub 2011 Oct 5.

Alzheimer's disease--input of vitamin D with mEmantine assay (AD-IDEA trial): study protocol for a randomized controlled trial

Annweiler C, Fantino B, Parot-Schinkel E, Thiery S, Gautier J, Beauchet O.

Trials. 2011 Oct 20;12:230. doi: 10.1186/1745-6215-12-230.

Treatment of Alzheimer disease: the past, the present, and the future

Gauthier S.

Can J Psychiatry. 2011 Oct;56(10):577-8. doi: 10.1177/070674371105601001.

Pharmacological treatment of Alzheimer disease

Massoud F, Léger GC.

Can J Psychiatry. 2011 Oct;56(10):579-88. doi: 10.1177/070674371105601003.

Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease

Miller BW, Willett KC, Desilets AR.

Ann Pharmacother. 2011 Nov;45(11):1416-24. doi: 10.1345/aph.1Q238. Epub 2011 Oct 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias